You are here

Pfizer mulls spin-off or sale of consumer health unit: sources

Friday, November 11, 2016 - 05:50

New York

US drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as US$14 billion, people familiar with the matter said on Wednesday.

A Pfizer exit from the consumer health business, which includes lip

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom